Literature DB >> 10070053

Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis.

D Q Wang1, F Lammert, D E Cohen, B Paigen, M C Carey.   

Abstract

Cholic acid is a critical component of the lithogenic diet in mice. To determine its pathogenetic roles, we fed chow or 1% cholesterol with or without 0.5% cholic acid to C57L/J male mice, which because of lith genes have 100% gallstone prevalence rates. After 1 yr on the diets, we measured bile flow, biliary lipid secretion rates, hepatic cholesterol and bile salt synthesis, and intestinal cholesterol absorption. After hepatic conjugation with taurine, cholate replaced most tauro-beta-muricholate in bile. Dietary cholic acid plus cholesterol increased bile flow and biliary lipid secretion rates and reduced cholesterol 7alpha-hydroxylase activity significantly mostly via deoxycholic acid, cholate's bacterial 7alpha-dehydroxylation product but did not downregulate cholesterol biosynthesis. Intestinal cholesterol absorption doubled, and biliary cholesterol crystallized as phase boundaries shifted. Feeding mice 1% cholesterol alone produced no lithogenic or homeostatic effects. We conclude that in mice cholic acid promotes biliary cholesterol hypersecretion and cholelithogenesis by enhancing intestinal absorption, hepatic bioavailability, and phase separation of cholesterol in bile.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070053     DOI: 10.1152/ajpgi.1999.276.3.G751

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  31 in total

Review 1.  Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8.

Authors:  Henning Wittenburg; Martin C Carey
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 2.  New insights into the molecular mechanism of intestinal fatty acid absorption.

Authors:  Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-09-18       Impact factor: 4.686

3.  Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice.

Authors:  Anne S Henkel; Mark H Kavesh; Michael S Kriss; Amanda M Dewey; Mary E Rinella; Richard M Green
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

4.  Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.

Authors:  Youcai Zhang; Andrew J Lickteig; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-22       Impact factor: 4.219

5.  Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.

Authors:  G A Clarke; G Bouchard; B Paigen; M C Carey
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

6.  Cholesterol: from feeding to gene regulation.

Authors:  C Martini; V Pallottini
Journal:  Genes Nutr       Date:  2007-09-27       Impact factor: 5.523

7.  Endogenous elevation of plasma cholecystokinin does not prevent gallstones.

Authors:  Rafiq A Shahid; David Q-H Wang; Brian E Fee; Shannon J McCall; Joelle M-J Romac; Steven R Vigna; Rodger A Liddle
Journal:  Eur J Clin Invest       Date:  2015-03       Impact factor: 4.686

8.  Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.

Authors:  David Q-H Wang; Frank Schmitz; Alan S Kopin; Martin C Carey
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 9.  Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes.

Authors:  David Q-H Wang; Nezam H Afdhal
Journal:  Curr Gastroenterol Rep       Date:  2004-04

10.  17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice.

Authors:  Amparo C Villablanca; Amy Tenwolde; Michael Lee; Melissa Huck; Shannon Mumenthaler; John C Rutledge
Journal:  J Cardiovasc Transl Res       Date:  2009-05-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.